US, Canadian pot firms eye Germany for growth as market stagnates at home

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 39 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 63%

Germany News

Illicit Market,Global Market,Medical Cannabis

North American cannabis firms, facing prohibitive laws, an overcrowded market and a deeply entrenched illicit sector at home are ramping up investments in...

- North American cannabis firms, facing prohibitive laws, an overcrowded market and a deeply entrenched illicit sector at home are ramping up investments in Germany after the country partly legalized marijuana use.

"Canadian market is very challenging for these producers and Germany is probably the largest opportunity for them," said Frederico Gomes, analyst at brokerage ATB Capital Markets. Canada's OrganiGram had in June announced a 14 million euro investment - 16.5% of its overseas investments funds - in Berlin-based Sanity Group.

Another draw is that Germany does not impose high taxes on medical marijuana sales, keeping prices competitive to the illicit market in contrast to Canada, OrganiGram CEO Beena Goldenberg said.BMO Capital Markets chief investment strategist Brian Belski joins Morning Brief to break down his chart for the Yahoo Finance Chartbook, which highlights the S&P 500 max drawdown during the second year of a bull market.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in US

United States United States Latest News, United States United States Headlines